Sensus Healthcare (SRTS)

• Market cap: $52.1M
• 1 day: 1.28%
• 5 days: -0.63%
• 1 month: -40.41%
• 3 months: -34.23%
• 6 months: -35.17%
• Year to date: -55.35%
• 1 year: -51.45%
• 5 years: 14.03%
• 10 years: -45.81%
• Sector: Healthcare
• Industry: Medical Devices

About: Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Employees: 54

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

6% more capital invested

Capital invested by funds: $19M [Q1] → $20.2M (+$1.13M) [Q2]

1.47% more ownership

Funds ownership: 24.41% [Q1] → 25.88% (+1.47%) [Q2]

15% less funds holding

Funds holding: 53 [Q1] → 45 (-8) [Q2]

27% less call options, than puts

Call options by funds: $37K | Put options by funds: $51K

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $6 89% upside
• Avg. target: $7 121% upside
• High target: $8 152% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Yi Chen	152% upside $8	Buy Maintained	12 Aug 2025
Lake Street Ben Haynor	89% upside $6	Buy Maintained	8 Aug 2025